Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent. Int J Dermatol 2014 Jan;53(1):e13-4
Date
09/25/2012Pubmed ID
22998756DOI
10.1111/j.1365-4632.2011.05350.xScopus ID
2-s2.0-84890794842 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
Randhawa J, Wong S, Atallah E, Olasz EAuthors
Ehab L. Atallah MD Professor in the Medicine department at Medical College of WisconsinEdit Olasz MD, PhD Associate Professor in the Dermatology department at Medical College of Wisconsin
Stuart J. Wong MD Center Director, Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AgedAntimetabolites, Antineoplastic
Azacitidine
Carcinoma, Squamous Cell
Humans
Immunosuppressive Agents
Keratoacanthoma
Kidney Transplantation
Male
Myelodysplastic Syndromes
Skin Neoplasms
Treatment Outcome